Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alaska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alaska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alaska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Angela Emerson (NPI 1669100921)

Field	Value
Entity Type	Individual
Organization	Angela Emerson
Address	1640 Cowles St
City	Fairbanks
State	AK
ZIP	99701
Taxonomy	Physician Assistant
NPI Enumerated	August 12, 2022

Payer Source	Total Paid
Medicare	$403.8K
Medicaid	$0

Key Findings

ANGELA EMERSON is a Physician Assistant in FAIRBANKS, AK with an NPI enumerated 2022-08-12 (~4 years ago). Lifetime Medicare revenue on file is $403.8K and there is no Medicaid billing on file, so the provider’s public claims footprint is effectively single-payer Medicare at present. This tenure and payer mix indicate a relatively recent entrant whose measurable billing activity is focused entirely within Medicare.

Revenue is highly concentrated: the precomputed top 3 Medicare codes account for 84.1% of this provider’s total Medicare revenue. Those top three codes are J9271 ($273K, 68.6% of Medicare revenue), 99214 ($34K, 8.6%), and 96413 ($27.6K, 6.9%), so a small set of product and service lines drives nearly all reported Medicare dollars.

The code mix is consistent with an oncology/infusion practice. J9271 (pembrolizumab injection) is the single largest revenue driver with 7K claims and $273K in revenue, and multiple chemotherapy administration codes (96413, 96417, G0498, 96375, 96367, 96365) appear among the top billings, signaling regular intravenous and infusion services alongside oncology drug administration. This pattern suggests the provider’s operations center on infusion-based cancer therapy and attendant office follow-up.

Despite J9271 being the dominant revenue source, the provider’s national competitive standing on that drug is modest: J9271 ranks #1520 of 1841 providers nationally (16th percentile) and is described in the file as "typical, unremarkable volume for this code." In other words, while J9271 generates $273K (68.6%) of this provider’s Medicare revenue, the provider is not a high-volume national outlier for pembrolizumab administration.

Evaluation-and-management activity is meaningful relative to the drug and infusion work: 99214 accounts for 324 claims and $34K in revenue and ranks #91663 of 479517 providers nationally (81st percentile), described as "typical, unremarkable volume for this code." Lower- and higher-complexity E/M codes (99213 and 99215) also appear in the top-25 list, indicating ongoing office-based visits and follow-up consistent with longitudinal oncology care.

Chemotherapy administration and add-on infusion codes show a consistent infusion footprint: 96413 (294 claims, $27.6K; ranks #1903 of 7514, 75th percentile), 96417 (118 claims, $5.5K; 71st percentile), and G0498 (51 claims, $6.6K; 56th percentile) are all present and described as "typical, unremarkable volume for this code." The presence of initiation, continuation, and add-on chemotherapy codes implies the practice administers multi‑drug regimens and both initial and ongoing infusion management in the outpatient/office setting.

Several high-claim, low-dollar supportive drug and infusion supply codes underline the operational profile: J0640 has 919 claims for $2.8K in revenue (avg $3/claim) and J2469 has 1K claims for $1K in revenue (avg $1/claim), while other supply/drug HCPCS like J9190 and J3489 also appear. In addition, some infusion service codes rank above average nationally (for example, 96375 ranks at the 82nd percentile and 96361 at the 87th percentile) and are described as "typical, unremarkable volume for this code," pointing to relatively elevated use of sequential IV push and IV fluid services within the overall infusion practice.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

35 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	7,000	$40	$273K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	320	$110	$34K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	290	$90	$27.6K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	70	$130	$9.9K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community…	50	$130	$6.6K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	120	$50	$5.5K
96375	Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the…	400	$10	$4.8K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	210	$20	$4.6K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	30	$140	$4K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	80	$50	$3.5K

Showing 1–10 of 35

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 35 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alaska Distribution

Angela Emerson — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alaska

Full comparison — all codes billed, vs. state median

35 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	13	10	13,300	$40	$609.5K
96413	9	20	230	$110	$30.2K
99214	157	1,210	90	$100	$16.2K
J9217	17	20	100	$130	$14.8K
99215	256	400	40	$150	$11K
99213	880	1,290	70	$70	$8.5K
G0498	5	10	50	$150	$7.5K
99205	115	140	30	$190	$7.4K
96401	8	10	70	$60	$6.2K
96417	6	20	100	$60	$5.3K

Showing 1–10 of 35

Related Providers

Other providers that share a Tax Identification Number (TIN) with Angela Emerson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Aimee Johnson	AK	Physician Assistant	$914.7K	$0
W William Cox	AK	Hematology & Oncology Physician	$472.4K	$0
Jacqueline Cox	AK	Hematology & Oncology Physician	$403.3K	$0
Britni Browning	AK	Physician Assistant	$256.7K	$0
Dennis Beckworth	GU	Medical Oncology Physician	$6K	$0

Nearby Providers

Other providers in the same ZIP code as Angela Emerson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Tanana Chiefs Conference	AK	Multi-Specialty Clinic/Center	$0	$107.5M
Fairbanks Memorial Hospital, LLC	AK	General Acute Care Hospital	$0	$83.6M
Fairbanks Resource Agency Inc	AK	Community/Behavioral Health Agency	$0	$48M
Presbyterian Hospitality House	AK	Emotionally Disturbed Childrens' Residential Treatment Facility	$0	$34.9M
Fairbanks Native Association	AK	Substance Abuse Rehabilitation Facility	$0	$32.6M
Tanana Chiefs Confenerce	AK	Transportation Broker	$0	$24.1M
Tanana Chiefs Conference	AK	Community/Behavioral Health Agency	$0	$17M
Tanana Chiefs Conference	AK	Multi-Specialty Clinic/Center	$0	$16.3M
Restore LLC	AK	Substance Use Disorder Rehabilitation Clinic/Center	$0	$16.3M
Tanana Valley Clinic LLC	AK	Multi-Specialty Clinic/Center	$0	$15.2M

Angela Emerson — Billing Profile & Reimbursement Data

Sign up for Angela Emerson — Billing Profile & Reimbursement Data policy alerts

Angela Emerson — Billing Profile & Reimbursement Data

Sign up for Angela Emerson — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References